|
||
|
Press ReleaseAccuro Biologics Ltd announces participation in oncology trade mission to USABERDEEN, UK -- Jan 22, 2007 -- Accuro Biologics Ltd, a privately held biotechnology services company, announces that it will be participating this week in an oncology focus trade mission to the US. The trip co-ordinated by Scottish Development International will enable participants to meet with some of the world's leading pharmaceutical and biotechnology companies to help open up new business opportunities. "Accuro Biologics is proving itself to be a reliable partner to the biopharma industry and we are delighted to be able to show case our expertise to such significant industry players in the Boston area," said Graham Carter, Managing Director of Accuro Biologics. "Boston and the wider Massachusetts state is regarded as one of the world's leading life sciences locations and home to some of the world's biggest pharmaceutical and biotech companies. Scotland's world-class reputation in the oncology field has helped us get the foot in the door with these global firms and this trip will be hugely important in promoting Scotland's strengths in oncology research, " said Ian Leslie, of Scottish Development International Life Sciences. About Accuro Biologics LtdAccuro Biologics is a specialist research services company to the pharmaceutical, biotechnology and wider research community. The company provides an outsourcing option for those requiring expert services in protein and antibody engineering, cell line development and immunogenicity (T cell epitope) profiling. Founded on a significant industry track record, the company delivers highly cost effective services with added value provided by adherence to time lines, budget and high quality science. The company is UK-based and operates from its own fully equipped laboratories within the Aberdeen Science and Technology Park, Aberdeen, Scotland. For more information, please contact: Graham Carter Tel: +44 (0)1224 707337 Return to Press Releases |
||
Printer Friendly